Gender Differences in Coronary Artery Disease: Review of Diagnostic Challenges and Current Treatment

References

• . Mosca L, Appel LJ, Benjamin EG,; American Heart Association. Evidence based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109(5):672–693
   PubMed Web of Science ®Google Scholar
• . Mazzaferri EL, Limacher MC. Changing patterns of CAD therapy and hormone usage for women. Cardiology Review. 2005;22(3):32–37
   Google Scholar
• . Lansky A. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovas Dis. 2004;46(4):305–319
   PubMed Web of Science ®Google Scholar
• . Hong S, Friedman J. The primary prevention of coronary heart disease in women: an overview. Cardiology Review. 2005;22(3):14–22
   Google Scholar
• . Mosca L, Merz N, Blumenthal R,. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005;111(4):488–493
   PubMed Web of Science ®Google Scholar
• . Mieres JH, Shaw LJ, Arai A,; Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111(5):682–696
   PubMed Web of Science ®Google Scholar
• . Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46(4):287–292
   PubMed Web of Science ®Google Scholar
• . Wenger NK. Cardiovascular health and disease in women–problems and prospects. Circulation. 2004;109:558–560
   PubMed Web of Science ®Google Scholar
• . Wenger NK. Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis. 2003;46(3):199–229
   PubMed Web of Science ®Google Scholar
• . Cohn J. Hormone replacement therapy revisited. Cardiology Review. 2005;22(3):40
   Google Scholar
• . Berger JS, Brown DL. Impact of gender on mortality following primary angioplasty for acute myocardial infarction. Prog Cardiovasc Dis. 2004;46(4):297–304
   PubMed Web of Science ®Google Scholar
• . Peterson P, Masoudi F, Rumsfeld J. Gender differences in the epidemiology and treatment of heart failure. Cardiology Review. 2005;22(3):24–29
   Google Scholar
• . Jacobs AK, Eckel RH. Evaluating and managing cardiovascular disease in women understanding a woman's heart. Circulation. 2005;111(4):383–384
   PubMed Web of Science ®Google Scholar
• . Redberg RF, Shaw LJ. Diagnosis of coronary artery disease in women. Prog Cardiovasc Dis. 2003;46(3):239–258
   PubMed Web of Science ®Google Scholar
• . Shaw LJ, Bairey Merz CN, Azziz R,. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health—National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93(4):1276–1284
   PubMed Web of Science ®Google Scholar
• . Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213–219
   PubMedGoogle Scholar
• . Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001;4(3):109–114
   PubMedGoogle Scholar
• . Adams MR, Kaplan JR, Manuck SB,. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 1990;10(6): 1051–1057
   PubMedGoogle Scholar
• . Arant CB, Wessel TR, Olson MB,; National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol. 2004;43(11):2009–2014
   PubMed Web of Science ®Google Scholar
• . Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341(4):217–225
   PubMed Web of Science ®Google Scholar
• . Hoffman LK, Ehrmann DA. Cardiometabolic features of polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2008;4(4):215–222
   PubMedGoogle Scholar
• . Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG. 2006;113(10):1203–1209
   PubMed Web of Science ®Google Scholar
• . Kolodgie FD, Virmani R, Burke AP,. Pathologic assessment of the vulnerable human coronary plaque. Heart. 2004;90(12):1385–1391
   PubMed Web of Science ®Google Scholar
• . Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97(21):2110–2116
   PubMed Web of Science ®Google Scholar
• . Milner KA, Funk M, Arnold A, Vaccarino V. Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J. 2002;143(2):283–288
   PubMed Web of Science ®Google Scholar
• . Milner KA, Funk M, Richards S, Wilmes R, Vaccarino V, Krumholz H. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol. 1999;84(4):396–399
   PubMed Web of Science ®Google Scholar
• . Scirica BM, Moliterno DJ, Every NR,. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. Am J Cardiol. 1999;84(10):1145–1150
   PubMed Web of Science ®Google Scholar
• . Arnold AL, Milner KA, Vaccarino V. Sex and race differences in electrocardiogram use (the National Hospital Ambulatory Medical Care Survey). Am J Cardiol. 2001;88(9):1037–1040
   PubMed Web of Science ®Google Scholar
• . McCord J, Nowak RM, McCullough PA. Ninety-minute exclusion of acute myocardial infarcion by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104(13):1483–1488
   PubMed Web of Science ®Google Scholar
• . Wiviott SD, Cannon CP, Morrow DA,. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 2004;109(5):580–586
   PubMed Web of Science ®Google Scholar
• . Gum PA, Kottke-Marchant K, Poggio ED,. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001;88(3):230–235
   PubMed Web of Science ®Google Scholar
• . Lev EI, Patel RT, Maresh KJ,. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006;47(1):27–33
   PubMed Web of Science ®Google Scholar
• . Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343(1):8–15
   PubMed Web of Science ®Google Scholar
• . Abuful A, Gidron Y, Henkin Y. Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol. 2005;28(8):389–393
   PubMed Web of Science ®Google Scholar
• . Mallik S, Vaccarino V. Outcomes of thrombolytic therapy for acute myocardial infarction in women. Prog Cardiovasc Dis. 2004;47(1):58–71
   PubMed Web of Science ®Google Scholar
• . Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999;83(5):660–666
   PubMed Web of Science ®Google Scholar
• . Michaelides AP, Fourlas CA, Chatzistamatiou EI, Andrikopoulos GK, Soulis D, Psomadaki ZD, Stefanadis CI. QRS score improves diagnostic ability of treadmill exercise testing in women. Coron Artery Dis. 2007;18(4):313–318
   PubMed Web of Science ®Google Scholar
• . Webb CM, Rosano GM, Collins P. Oestrogen improves exercise-induced myocardial ischaemia in women. Lancet. 1998;351(9115):1556–1567
   PubMed Web of Science ®Google Scholar
• . Kawano H, Motoyama T, Ohgushi M, Kugiyama K, Ogawa H, Yasue H. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med. 2001;135(11):977–981
   PubMed Web of Science ®Google Scholar
• . Lloyd GW, Patel NR, McGing E, Cooper AF, Brennand-Roper D, Jackson G. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart. 2000;84(2): 189–192
   PubMed Web of Science ®Google Scholar
• . Panting JR, Gatehouse PD, Yang GZ,. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948–1953
   PubMed Web of Science ®Google Scholar
• . Vermeltfoort IA, Bondarenko O, Raijmakers PG,. Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J. 2007;28(13):1554–1558
   PubMed Web of Science ®Google Scholar
• . Buchthal SD, den Hollander JA, Merz CN,. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342(12):829–835
   PubMed Web of Science ®Google Scholar
• . Johnson BD, Shaw LJ, Buchthal SD; National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(24):2993–2999
   PubMed Web of Science ®Google Scholar
• . Wilson GT, Gopalakrishnan P, Tak T. Noninvasive cardiac imaging with computed tomography. Clin Med Res. 2007;5(3):165–171
   PubMedGoogle Scholar
• . Gopalakrishnan P, Wilson GT, Tak T. Accuracy of multislice computed tomography coronary angiography: a pooled estimate. Cardiology Review. 2008;16(4):189–196
   PubMed Web of Science ®Google Scholar
• . Pundziute G, Schuijf JD, Jukema JW,. Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart. 2008;94(1):48–52
   PubMed Web of Science ®Google Scholar
• . Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology. 1999;10(5):476–480
   PubMed Web of Science ®Google Scholar
• . Varas-Lorenzo C, García-Rodríguez LA, Perez-Gutthann S, Duque-Oliart A. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation. 2000;101(22):2572–2578
   PubMed Web of Science ®Google Scholar
• . Hulley S, Grady D, Bush T,. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–613
   PubMed Web of Science ®Google Scholar
• . Grady D, Herrington D, Bittner V; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288(1):49–57
   PubMed Web of Science ®Google Scholar
• . Rossouw JE, Anderson GL, Prentice RL; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333
   PubMed Web of Science ®Google Scholar
• . Anderson GL, Limacher M, Assaf AR; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–1712
   PubMed Web of Science ®Google Scholar
• . Cherry N, Gilmour K, Hannaford P; ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002;360(9350):2001–2008
   PubMed Web of Science ®Google Scholar
• . Herrington DM, Reboussin DM, Brosnihan KB,. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 2000;343(8):522–529
   PubMed Web of Science ®Google Scholar
• . Schulman SP, Thiemann DR, Ouyang P,. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. J Am Coll Cardiol. 2002;39(2):231–237
   PubMed Web of Science ®Google Scholar
• . Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol. 2007;166(5):506–510
   PubMed Web of Science ®Google Scholar
• . Hodis HN. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart. Cleve Clin J Med. 2008;75( suppl 4):S3–S12
   PubMedGoogle Scholar
• . Rossouw JE, Prentice RL, Manson JE,. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465–1477
   PubMed Web of Science ®Google Scholar
• . Manson JE, Allison MA, Rossouw JE; WHI and WHI-CACS Investigators. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356(25):2591–2602
   PubMed Web of Science ®Google Scholar
• . Salpeter SR, Walsh JM, Greyber E, Salpeter EE. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med. 2006;21(4):363–366
   PubMed Web of Science ®Google Scholar
• . American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease. Committee on Gynecologic Practice. Obstet Gynecol. 2008;112(5):1189–1192
   PubMedGoogle Scholar